AltraVue Capital, LLC

Q2 2021 13F Combination Report, Restatement, Stock Holdings

Signature - Title
Thomas Parkhurst - Chief Compliance Officer
Location
Bellevue
Holdings as of
June 30, 2021
Value $
$564M
Num holdings
33
Date filed
8/24/2021, 12:41 PM
Form type
13F-HR/A-1 - Restatement
Description
A portion of the US holdings for this investor are reported in this report and a portion are reported by other reporting manager(s). Top holdings included CDMO, QADA, SNEX, NOMD, and AGYS.
Previous filing
Q1 2021 - Aug 24, 2021
Next filing
Q3 2021 - Oct 29, 2021
SEC
View on sec.gov
Sym Weight Trade Impact Company Class Shares Change Activity Value Change $ Value $ * Price $ Shares Principal
Filing 2021 Q2 - Restatement compared to 2021 Q1 - Restatement by default.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Thomas Parkhurst Chief Compliance Officer Bellevue, Washington 8/24/2021

List of Other Managers Reporting for AltraVue Capital, LLC:

Name Holdings Value Location File Number
Legato Capital Management LLC $918M San Francisco, CA 028-13158
Acuitas Investments, LLC $156M Seattle, WA 028-16461

Other Included Managers (2):

Num Name Location File Number
1 Acuitas Investments, LLC Seattle, WA 028-16461
2 Legato Capital Management LLC San Francisco, CA 028-13158